Overview
Elevated LDL cholesterol is a major risk factor for cardiovascular disease. While statins remain first-line therapy, several supplements have demonstrated clinically meaningful LDL reductions in randomized trials and may serve as adjuncts or alternatives for those with mild elevations or statin intolerance.